Overview

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nalfurafine hydrochloride is effective and safe in the treatment for conventional-treatment-resistant pruritus in patients receiving hemodialysis.
Phase:
Phase 3
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.
Collaborator:
Toray Industries, Inc